Skip to main content

Table 2 Summary of patient demographic and healthcare utilisation characteristics in differing HCV health-states

From: Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study

Characteristic

Mild

Mod.

Comp. Cirrhosis

Decomp. Cirrhosis

HCC

Transplant Year 1

Transplant > Year 1

SVR

N

40

29

24

13

27

33

31

28

Mean Age (SD)

38 (8)

48 (10)

45 (9)

46 (7)

55 (11)

47 (9)

54 (9)

34 (10)

Male n (%)

25 (61)

16 (55)

25 (89)

12 (98)

23 (85)

22 (67)

19 (66)

22 (79)

Patient years of follow-up

214

137

102

23

39

33

187

84

Annual mean number of medical reviews (95%CI)

1.3 (1.1, 1.5)

1.4 (1.2,1.7)

1.8 (1.5, 2.1)

4.6 (4.2, 4.9)

5.2 (4.6, 5.8)

11.9 (10.4, 13.2)

4.3 (4.0, 4.6)

0.36 (0.22, 0.5)

Annual mean number of nursing reviews (95 % CI)

0.5 (0.3, 0.7)

0.9 (0.6, 1.2)

1.8 (0.9, 2.6)

5.1 (4.3,5.9)

3.6 (3.1, 4.1)

n/a

n/a

0.1 (0.0, 0.04)

Annual mean number of inpatient episodes (95%CI)

n/a

n/a

0.2 (0.06, 0.4)

2.5 (2.1, 3.0)

2.1 (1.8, 2.3)

1.1 (0.6, 1.6)

0.24 (0.1, 0.38)

n/a

  1. Mod moderate, Comp. cirrhosis Compensated cirrhosis, Decomp. Cirrhosis decompensated cirrhosis, HCC hepatocellular carcinoma, Transplant Year 1 First 12 months of liver transplantation, Transplantation > Year 1 Transplantation After First 12 months, SVR Sustained Viral Response